Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
03/2007
03/21/2007CN1934246A Cancerous disease modifying antibodies
03/21/2007CN1934101A Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
03/21/2007CN1933854A Therapeutic agent for auris interna disorder containing il-6 antagonist as active ingredient
03/21/2007CN1933829A Methods for treating resistant or refractory tumors
03/21/2007CN1933813A Compositions and methods for delivery of biologically active agents
03/21/2007CN1932017A Tumor adoptosis inducing ligandin and its application in preparing antitumor medicine
03/21/2007CN1932016A Polynucleotide affecting SRE activity and its coding polypeptides and use
03/21/2007CN1931877A Prepn and use of CD20 antagonizing Chimeric antibody
03/21/2007CN1931871A New triterpene saponin componds with anticancer activity
03/21/2007CN1931869A Derivative of 5-deoxy-5-fluoro cytidine and its prepn process and use
03/21/2007CN1931867A Active dextran tetra saccharide alkyl glycoside and its prepn process and application
03/21/2007CN1931859A New fused imidazole derivative
03/21/2007CN1931851A Compound 2,3,4,6,8-pentamethoxyl-dibenzofuran and its use
03/21/2007CN1931840A DNA target molecules and their application in inducing apoptosis and antagonizing tumor
03/21/2007CN1931373A Correlation of cofilin 1 and resistance to anticancer taxane chemotherapy medicine
03/21/2007CN1931369A Medicine composition containing cyclodextrin/polyene taxol and its prepn process
03/21/2007CN1931368A Medicine composition containing cyclodextrin included taxol and its prepn process
03/21/2007CN1931366A Anticancer biological missile medicine
03/21/2007CN1931352A Chinese medicine composition and its prepn process
03/21/2007CN1931346A Anticancer soft capsule and its prepn process
03/21/2007CN1931314A Medicine and its prepn process
03/21/2007CN1931312A Anticancer Chinese medicine prepn and its prepn process
03/21/2007CN1931296A Pinellia tuber extract and its prepn process, medicine composition and use
03/21/2007CN1931286A Chinese medicine composition for treating lung cancer caused pain
03/21/2007CN1931285A Chinese medicine composition and its prepn process
03/21/2007CN1931271A Evodia extract and its prepn process, medicine composition and use
03/21/2007CN1931259A Process of extracting effective component from papaya
03/21/2007CN1931237A Compound Chinese medicine prepn for treating malignant tumor
03/21/2007CN1931219A Gynostemma pentaphylla micro emulsion medicine and its prepn
03/21/2007CN1931190A Toad skin extract and its medicine prepn and their prepn
03/21/2007CN1931178A Pirarubicin liposome and its prepn process
03/21/2007CN1931173A Application of diosgenin in preparing medicine with synergistic attenuation
03/21/2007CN1931158A Compound emulsion of docetaxel and volatil Chinese medicine oil for intravenous injection and its prepn process
03/21/2007CN1931157A Polyene taxol liposome and its prepn process
03/21/2007CN1931156A Nanometer solid taxol lipoid particle and its prepn process
03/21/2007CN1931152A Application of shikonin in preparing medicine for inducing apoptosis
03/21/2007CN1931150A Elemene soft capsule and its prepn process
03/21/2007CN1931136A Nanometer NAMI-A particle and its prepn process and application
03/21/2007CN1306020C Polyporus frondosus oral liquor and its production method
03/21/2007CN1305899C Therapeutic peptides
03/21/2007CN1305890C 17a-fluoroalkyl steroids method for producing the same and pharmaceutical compositions containing said compounds
03/21/2007CN1305872C Process for producing quinazoline ditosylate salt compounds
03/21/2007CN1305860C Condensed quinazoline derirative used as tyrosine kinase inhibitor
03/21/2007CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
03/21/2007CN1305839C Phenylglycine derivatives
03/21/2007CN1305528C Immunoadjuvant
03/21/2007CN1305515C Chinese medicine powder and decoction composition for treating cancers
03/21/2007CN1305496C Green tea medicine for treating and preventing cancer and tumor, its preparation. method and application
03/21/2007CN1305480C Antineoplastic medicinal composition, its preparation method and application
03/21/2007CN1305479C Low polarity ginsenoside combination possessing anti-tumor activity
03/21/2007CN1305478C Freeze drying preparation of amifostine, and preparation method
03/21/2007CN1305475C Boronic ester and acid compounds, synthesis and uses
03/21/2007CN1305473C Rubitecan containing formulation for injection
03/21/2007CN1305471C Use of sophoridine oxide in preparing anticancer medicine
03/21/2007CN1305468C Bolengsu compound and its preparation, medicine composition and use
03/21/2007CN1305466C Application of Cytospora bacterin B in preparation of antineoplastic medicine
03/20/2007US7193108 Phenylpropionic acid derivatives
03/20/2007US7193081 Process for preparation of cyclic prodrugs of PMEA and PMPA
03/20/2007US7193064 antibody or a functional fragment thereof that recognizes a human CD40 antigen present on the surface of human B cells, dendritic cells
03/20/2007US7193040 Apoptosis of rectum and prostate cancer
03/20/2007US7192980 Such as 6-[14-[(aminocarbonyl)oxy]-2,6,12-trihydroxy-5,7,9,11,13,15-hexamethyl-3,8,16,18-nonadecatetraenyl]tetrahydro-(6R)-2H-pyran-2-one; high selectivity; colon cancer
03/20/2007US7192977 Duocamycin prodrugs; binding to Dna
03/20/2007US7192975 Arylimidazole derivatives, preparation and therapeutic used thereof
03/20/2007US7192972 Prevention of restenosis of blood vessels after trauma, angioplasty or stenting; piperidin-2-amide derivatives; anticarcinogenic agents
03/20/2007US7192967 Cyclic imide-substituted pyridylalkane, alkene, alkine carboxamides useful as cytostatic and immunosuppressive agents
03/20/2007US7192963 Janus Kinase 3 inhibitors; organ transplant rejection, xeno transplation, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, leukemia, and autoimmune diseases
03/20/2007US7192962 Enzyme hydrolase inhibitors such as 1-ethyl-3,7-dihydro-8-((1 R,2R)-(hydroxycyclopentyl)amino)-3-(2-hydroxyethyl)-7-((3-bromo-4 -methoxyphenyl)methyl)-1H-Purine-2,6-dione, used for physiological effects
03/20/2007US7192961 1-Carbonyl-4-(4-quinoline-)-piperazine or 1-carbonyl-4-[4-(1H-quinolin-2-{thio}one)-piperazine derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment
03/20/2007US7192956 Inducing contraception by delivering to a female of child-bearing age a selective estrogen receptor modulator comprising cyclothiocarbamate derivative
03/20/2007US7192955 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/20/2007US7192949 Anticarcinogenic and antiproliferative agents
03/20/2007US7192942 Wet milling while crystallizing to obtain a primary particle suspension.
03/20/2007US7192940 Ether compounds
03/20/2007US7192929 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
03/20/2007US7192927 An isolated BAX gene frameshift-mutation polypeptide is used to stimulate the proliferation of human T cells, T cellular immunity; for treating cancer patient; cancer vaccines
03/20/2007US7192733 screening for drugs that inhibit prostaglandin endoperoxidase (PGE) synthase, for use in treatment of inflammation, arthritis, cancer, Alzheimer's disease, in modulating apoptosis, and treating pain
03/20/2007US7192715 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
03/20/2007US7192706 Growth regulating proteins
03/20/2007US7192582 Human monoclonal antibodies to FC alpha receptor (CD89)
03/20/2007US7192580 Purging of cells using viruses
03/20/2007US7192570 Compositions of somatostatin analogues
03/20/2007CA2297326C Heterocyclic compound and antitumor agent containing the same as active component
03/20/2007CA2205868C Trinuclear cationic platinum complexes having antitumour activity and pharmaceutical compositions containing them
03/15/2007WO2007030780A2 Quinoline derivatives and use as antitumor agents
03/15/2007WO2007030680A2 Triazole derivatives useful as axl inhibitors
03/15/2007WO2007030377A1 Substituted benzimidazoles as kinase inhibitors
03/15/2007WO2007030361A2 Benzimidazole thiophene compounds as plk inhibitors
03/15/2007WO2007030359A1 Benzimidazole thiophene compounds as plk modulators
03/15/2007WO2007030080A1 Heterocyclic compounds
03/15/2007WO2007029847A1 Bicyclic aromatic substituted pyridone derivative
03/15/2007WO2007029760A1 Pharmaceutical for use in prevention and/or treatment of bowel disease
03/15/2007WO2007029689A1 Method for activation treatment of antigen-presenting cell
03/15/2007WO2007029629A1 Indolecarboxylic acid derivative having pgd2 receptor antagonistic activity
03/15/2007WO2007029361A1 Sustained-release microsphere containing short chain deoxyribonucleic acid or short chain ribonucleic acid and method of producing the same
03/15/2007WO2007029251A2 Polyalkylene glycol derivatives of 4- (phenylamino)quinazolines useful as irreversible inhibitors of epidermal gr0wth fact0r receptor tyrosine kinase
03/15/2007WO2007029107A1 Isoquinolines derivatives as igf-1r inhibitors
03/15/2007WO2007029106A1 Isoquinolines as igf-1r inhibitors
03/15/2007WO2007028999A1 Thiazole compounds and their use as pgd2 antagonists
03/15/2007WO2007028341A1 Nano anticancer micelles of vinca alkaloids entrapped in polyethylene glycolylated phospholipids
03/15/2007WO2007028196A1 Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
1 ... 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 ... 2211